Axxonis Pharma have submitted a MAA for:
- Nenad lisuride transdermal patch for the add on treatment of Parkinson’s Disease and Restless Legs Syndrome
- Nenal subcutaneous lisuride infusion for advanced Parkinson’s Disease
Filed under: gpcr | Tagged: agonist, Axxonis, Dopamine D2, Leovan, lisuride, Nedad, Prestwick | Leave a Comment »
Allergan intends to file a NDA by end of the third quarter of 2008 for bimatoprost as a treatment to stimulate eyelash growth. It is already launched as a treatment for ocular hypertension and glaucoma
Filed under: gpcr | Tagged: agonist, Allergan, bimatoprost, Lumigan, Prostaglandin | Leave a Comment »
AstraZeneca have filed supplemental New Drug Application to the FDA for approval of Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol in paediatric patients ages 6 to 11 years old.
Filed under: gpcr | Tagged: agonist, Astrazeneca, Beta 2 adrenoceptor, Formoterol, Symbocort | Leave a Comment »
